Point of Care
Remote Specialist screening and Diagnosis.
Cervical cancer is the second most common cancer in women worldwide and the leading cause of cancer deaths in developing countries. 83% of all new cases that occur annually and 85% of all 270,000 annual deaths from the disease occur in developing countries. Cervical cancer is the most common cancer among women in sub-Saharan Africa, and the increase disease and deaths is due to limited access to screening, diagnosis and treatment services for target women. The incidence is on the increase in many countries. We are solving this with the most cost effective and innovative Med-Tech solutions.
Remote Specialist screening and Diagnosis.
Applicable to all diagnostic process: VIA, VILI, Pap Smear, HPV-DNA.
Easy workflow and Fast turnaround time
Best patient comfort and most efficient health provider observation.
Breast cancer is now the most frequent cancer among women worldwide with up to a million cases occurring annually. In the developing world at large, the rate of screening is very low with screening techniques such as Mammography present only in big cities and its cost proves to be a limiting factor to accessibility and affordability by the rural populations especially. Most cases are thus diagnosed at late to end stage of the disease, where treatment options are very limited and prognosis very poor. Pathology confirmation is equally a huge problem owing to the limited number of Medical Pathologists and Pathology laboratories in the developing world. We are changing that. Our innovative tech enabled solutions enable any women get screened and diagnosed anywhere, and obtain results 90 times faster than usual cases.
Remote Specialist screening and Diagnosis.
Introducing the concept of digital microscopy and Tele-pathology in rural areas.
Easy workflow and Fast turnaround time especially for pathology diagnosis.
Instant second and third opinions and reviews.
An amazing technological breakthrough, with a harnessed advanced smartphone application combined to state-of-the-art medical engineering, to produce a device serving both as a colposcope and a speculum. The world’s first Smart Speculum. With C-Spec, gynecological examinations will be more comfortable and efficient like never before.
Better visibility of the cervix, with best comfort reported.
A colposcope + a speculum in one portable device.
Minimal training required.
99p of women prefer the C-Spec compared to any other speculum.
The GICMED FNA Device is designed to be used for precise fine needle aspiration biopsy (FNAB) procedures. It can be used on any nodule or lump that can be palpated or visualized with ultrasound, in organs such as breast lesions (lump and cystic), Lymph nodes (lymphadenopathies), Thyroid. It is suitable for cytology diagnostic purposes such as but not limited to, breast tumors staging and diagnosis, thyroid tumors, suspected lymphoma or lymph node metastasis.
can be used with any 10cc syringe design or model..
Enables quick and easy fine needle aspirate biopsy, with higher biopsy yield..
made from plastic, light weight and reusable.
Single hand use, and easily originating the vacuum into the syringe.
Using a combination of hardware and software technologies, we enabling everyone access pathology diagnosis at the point of care and in a faster turnaround time. Medical pathologists are one of the scarcest experts in the developing world and access to pathology services is very limited. Our digital pathology solution enables quickly diagnosing acute illnesses, chronic diseases and rare conditions, and accelerates the path to treatment.
pioneer in decentralizing pathology diagnosis that work even in rural settings.
Obtaining results 100 times faster than usual cases..
with the capacity of digitalizing slides, we are gradually moving to becoming the most diverse cancer registry in Sub-Saharan Africa.
Integrates all required steps; from sample preparations, to staining, digitalizing slides, diagnosis, second opinions and storage.